Wnt3a upregulates brain-derived insulin by increasing NeuroD1 via Wnt/β-catenin signaling in the hypothalamus

Abstract

BackgroundInsulin plays diverse roles in the brain. Although insulin produced by pancreatic β-cells that crosses the blood–brain barrier is a major source of brain insulin, recent studies suggest that insulin is also produced locally within the brain. However, the mechanisms underlying the production of brain-derived insulin (BDI) are not yet known.ResultsHere, we examined the effect of Wnt3a on BDI production in a hypothalamic cell line and hypothalamic tissue. In N39 hypothalamic cells, Wnt3a treatment significantly increased the expression of the Ins2 gene, which encodes the insulin isoform predominant in the mouse brain, by activating Wnt/β-catenin signaling. The concentration of insulin was higher in culture medium of Wnt3a-treated cells than in that of untreated cells. Interestingly, neurogenic differentiation 1 (NeuroD1), a target of Wnt/β-catenin signaling and one of transcription factors for insulin, was also induced by Wnt3a treatment in a time- and dose-dependent manner. In addition, the treatment of BIO, a GSK3 inhibitor, also increased the expression of Ins2 and NeuroD1. Knockdown of NeuroD1 by lentiviral shRNAs reduced the basal expression of Ins2 and suppressed Wnt3a-induced Ins2 expression. To confirm the Wnt3a-induced increase in Ins2 expression in vivo, Wnt3a was injected into the hypothalamus of mice. Wnt3a increased the expression of NeuroD1 and Ins2 in the hypothalamus in a manner similar to that observed in vitro.ConclusionTaken together, these results suggest that BDI production is regulated by the Wnt/β-catenin/NeuroD1 pathway in the hypothalamus. Our findings will help to unravel the regulation of BDI production in the hypothalamus.Electronic supplementary materialThe online version of this article (doi:10.1186/s13041-016-0207-5) contains supplementary material, which is available to authorized users.

Effect of developmental NMDAR antagonism with CGP 39551 on aspartame-induced hypothalamic and adrenal gene expression

“…Hypothalamic neuronal genes such as neurogenic differentiation 1 ( Neurod1 ) and cerebellin 3 precursor protein ( Cbln3 ) were upregulated in ASP+CGP mice, whereas a number were downregulated including Dapl1 , Fmod , Lcn2 , Prg4 and Phxr4 . Neurod1 is a transcription factor which regulates expression of the insulin gene [ 113 ], and mutations in Neurod1 are associated with type 2 diabetes [ 114 ]. Cerebelin in the brain modulates synaptic structure formation whereas in peripheral tissues it regulates catecholamine secretion and also may modulate insulin secretion [ 115 ].…”

Hypothalamic AMPK-induced autophagy increases food intake by regulating NPY and POMC expression

“…21,90,91 Immunoblot analysis Cell and tissue samples were lysed in lysis buffer. 92 Samples were dissolved in 50 mM Tris-HCl, pH 7.4, 250 mM sucrose (Bioshop, SUC507), 5 mM sodium pyrophosphate, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100 (Sigma, T8787), 0.1 mM benzamidine (Sigma, B6506), 1 mM DTT, 0.5 mM PMSF (Sigma, P7626), 50 mM NaF, protease inhibitor cocktail (Calbiochem, 535140), and phosphatase inhibitor cocktail (Sigma, P5726). Lysates were resolved on SDS-polyacrylamide gels and blotted onto PVDF membranes (Millipore, IPVH00010) for 35 min at 20 V in transfer buffer (25 mM Tris base, pH 7.4, 192 mM glycine, 10% methanol).…”

Type 2 Diabetes, Cognition, and Dementia in Older Adults: Toward a Precision Health Approach

“…Insulin is readily transported into the CNS across the blood-brain barrier via a saturable, receptor-mediated process, which likely accounts for the majority of available insulin in the brain (11). Additionally, recent evidence suggests that insulin is also produced in the brain, a process that is potentially regulated by the Wnt/β-catenin/NeuroD1 pathway in the hypothalamus (12), although this has yet to be verified in human studies. Regardless of source, the CNS is rich with insulin receptors, most prominently in areas important for learning and memory, including the hippocampus, amygdala, parahippocampal gyrus, thalamus, and caudate-putamen (13).…”